Pediatric News - Strattera
Friday, January 9th, 2009 Strattera (atomoxetine HCl, Eli Lilly & Co.)
The Food and Drug Administration approved Strattera for attention-deficit/hyperactivity disorder maintenance therapy in children and adolescents aged 6 years and older. This is the first FDA-approved agent for ma…
